Back to Search
ARIELLE MOSS, DO
DO
Student in an Organized Health Care Education/Training Program
NPI: 1023706389Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (20)
Impact of concomitant immunomodulator use on long-term outcomes in patients receiving scheduled maintenance infliximab.
PMID 19533357·Dig Dis Sci·2010
8-other
SCG3 transcript in peripheral blood is a prognostic biomarker for REST-deficient small cell lung cancer.
PMID 19118055·Clin Cancer Res·2009
8-other
NAD(P)H oxidase polymorphism (C242T) and high HDL cholesterol associate with recurrent coronary events in postinfarction patients.
PMID 17214994·Atherosclerosis·2008
8-other
The impact of infliximab infusion reactions on long-term outcomes in patients with Crohn's disease.
PMID 18485127·Aliment Pharmacol Ther·2008
8-other
Ranolazine shortens repolarization in patients with sustained inward sodium current due to type-3 long-QT syndrome.
PMID 18662191·J Cardiovasc Electrophysiol·2008
2-rct
Steroid-refractory severe ulcerative colitis: what are the available treatment options?
PMID 18547130·Drugs·2008
6-review
How often is a diagnosis of ulcerative colitis changed to Crohn's disease and vice versa?
PMID 18816774·Inflamm Bowel Dis·2008
8-other
Utility of the "surprise" question to identify dialysis patients with high mortality.
PMID 18596118·Clin J Am Soc Nephrol·2008
4-observational
The risks and the benefits of mesalazine as a treatment for ulcerative colitis.
PMID 17367256·Expert Opin Drug Saf·2007
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 550 UNIVERSITY BLVD STE 2440
INDIANAPOLIS, IN 46202 - Phone
- (317) 948-5923
Quick Facts
- NPI
- 1023706389
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile